The pharma group did not break down the details of the license to get control of STX-478, described as a next-generation PI3K alpha inhibitor for breast cancer and other advanced solid tumours ...

Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge the company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.

STX-478 is a once-daily oral, mutant-selective PI3Kα inhibitor currently being evaluated in a Phase 1/2 clinical trial for breast cancer and other advanced solid tumors. Eli Lilly and Company ...

Seagate Technology Holdings plc ( NASDAQ:STX ) just reported some strong earnings, and the market reacted accordingly... Everyone is looking for an edge in the market. Options trading is one way ...

Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

To learn more, visit our Investing in Stacks guide. Buy Token – Use your deposited funds to purchase the token (STX) seamlessly. We list the top 6 exchanges that offer the ability to buy Stacks (STX) ...

The current price of Stacks (STX) is $1.02, as of February 4, 2025. Over the last 24 hours, the price has moved by 11.12%, with a change of 1.38% in the past hour. For longer-term performance, the ...

Earnings Report 1.560 USD Q3 2022 Earnings Release 04/27/2022 Indices Commodities Currencies Stocks ...